Ergoteles’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-76,112
Closed -$9.01M 1803
2021
Q1
$9.01M Buy
76,112
+33,125
+77% +$3.92M 0.28% 92
2020
Q4
$5.08M Buy
+42,987
New +$4.99M 0.17% 138

Ergoteles's CBPO Position: Q2 2021 in Review

Ergoteles sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 76,112 shares — an estimated $9.01M sold.

Ergoteles first reported a position in CBPO in Q4 2020 and held it in 2 quarters. The position peaked at $9.01M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Ergoteles reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ergoteles sold 76,112 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $9.01M.
  • Ergoteles first reported a position in China Biologic Products Holdings, Inc. in Q4 2020 and held it in 2 quarters.
  • Ergoteles's China Biologic Products Holdings, Inc. position peaked at $9.01M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.